Alpha Tau Medical(DRTSW)
JERUSALEM, Israel
BiotechnologyFocus: Radiotherapy for Solid Tumors
Alpha Tau Medical is a life sciences company focused on Radiotherapy for Solid Tumors.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Radiation: Diffusing Alpha Radiation Emitters Therapy
Pancreatic CancerClinical Trials (1)
NCT06755359Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
N/ADiffusing Alpha Radiation Emitters Therapy
Breast CancerClinical Trials (1)
NCT06202118A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Pancreatic CancerClinical Trials (1)
NCT06698458Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Skin CancerClinical Trials (1)
NCT04540588Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
N/ADaRT seeds
Recurrent Squamous Cell CarcinomaClinical Trials (1)
NCT05323253A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma
N/ADiffusing Alpha Radiation Emitters Therapy
Squamous Cell CarcinomaClinical Trials (1)
NCT03015883Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma
N/ADiffusing Alpha Radiation Emitters Therapy
Head and Neck Squamous Cell CarcinomaClinical Trials (1)
NCT05047094A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Pancreatic CancerClinical Trials (1)
NCT05657743A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
N/AExperimental: DaRT seeds
Malignant TumorClinical Trials (1)
NCT05781555A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Prostate CancerClinical Trials (1)
NCT07290998Treatment of Locally Recurrent Prostate Cancer
N/AExperimental: DaRT seeds
Non-metastatic Prostate CancerClinical Trials (1)
NCT06202248A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer
N/ADaRT seeds
Squamous Cell CarcinomaClinical Trials (1)
NCT06615635Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Prostate AdenocarcinomaClinical Trials (1)
NCT04543903Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
N/ADaRT- Diffusing Alpha-emitters Radiation Therapy
Skin CancerClinical Trials (1)
NCT04068155Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Squamous Cell CarcinomaClinical Trials (1)
NCT05065346Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
N/ADiffusing Alpha-emitter Radiation Therapy
Malignant Skin TumorClinical Trials (1)
NCT04377360Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Skin CancerClinical Trials (1)
NCT03737734Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
N/ADiffusing Alpha Radiation Emitters Therapy
Liver MetastasesClinical Trials (1)
NCT05829291Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)
N/ADevice: Radiation: Diffusing Alpha Radiation Emitters Therapy
Breast CarcinomaClinical Trials (1)
NCT03970967Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Skin Squamous Cell CarcinomaClinical Trials (1)
NCT03353077Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)
N/ADevice: Radiation: Diffusing Alpha Radiation Emitters Therapy
Skin CancerClinical Trials (1)
NCT03886181Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Skin CancerClinical Trials (1)
NCT03889899Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
N/ADaRT Diffusing Alpha-emitters Radiation Therapy
Vulva Cancer, RecurrentClinical Trials (1)
NCT04761146A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Recurrent Lung CancerClinical Trials (1)
NCT05632913Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer
N/ADaRT seeds insertion
Pancreatic CancerClinical Trials (1)
NCT06026943Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer
N/ADaRT seeds
Carcinoma of the VulvaClinical Trials (1)
NCT06202339Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).
N/AA Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alph
Squamous Cell CarcinomaClinical Trials (1)
NCT05125354A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Pancreatic CancerClinical Trials (1)
NCT04002479Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer
N/ARadiation: Diffusing Alpha Radiation Emitters Therapy
Skin CancerClinical Trials (1)
NCT04534127Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
N/ADevice :DaRT seeds
Recurrent GlioblastomaClinical Trials (1)
NCT06910306A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma
N/AOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2016
Portfolio: 30 clinical trials